Generex Biotechnology Corp (NASDAQ:GNBT)

$0.63 -0.01 (-2.34%)
3/12/2010 4:00 PM
CAPS Rating 3 out of 5 
Open $0.64
Previous Close $0.64
Daily Range $0.62 - $0.64
52-Week Range $0.18 - $1.14
Market Cap $158.49M
P/E Ratio 0.00
Dividend (Yield) N/A (N/A)
Volume 1,135,581
Average Daily Volume 0
GNBT VS S&P 500 (SPY)

GNBT News and Commentary

This ticker is not currently Ratable.

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Members

182 Outperform
11 Underperform
 

All-Star Members

21 Outperform
2 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top GNBT Bull/Bear Pitches

Voyt608 (< 20)
Submitted January 08, 2008

GNBT's Oral insulin delivery system is a significant advancement in the treatment of Diabetes Mellitus and will be soon approved for use in the USA. It will be a cash cow, funding the companies cancer treatment programs for the foreseeable future.More

pobeda1 (< 20)
Submitted October 23, 2006

Incompetent management. Achieved virtually nothing in the past 10 years. Extremely poor fundamentals. Conduct unconventional clinical trials to avoid FDA pathway.

Featured Broker Partners